This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.
The Biofourmis armband wearable, Everion, is worn 24/7 and captures the patient’s temperature, blood oxygenation and numerous other physiologic signals to detect signs of decompensation, while the patient also reports any symptoms to their healthcare provider through a mobile app. iRhythm Technologies. Spry Health. Vivify Health.
They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.
The largest funding rounds in 2018 went to companies working on healthcaretechnology solutions such as Rhythm Pharmaceuticals, which raised $151 million, and Modernizing Medicine, which raised $231 million. Another challenge that Olive AI has faced is increased competition in the healthcaretechnology space.
Covid-19 has presented a rapid increase in mobile health app usage in the short term; however, in the long run, this situation will result in the acceleration and wider adoption of digital solutions, especially those with remotecare components. Before the pandemic, technology had been largely on the back-foot in most hospitals.
But this shift can redefine the way healthcare providers engage with patients, driving a more dynamic, agile, and patient-centered model of care delivery. Enhanced compliance with regulations like HIPAA and FHIR standards will prioritize the secure exchange and storage of healthcare data.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content